Zeropar Aerosol

Indications

• Bacterial infections
• Fungal infections
• Topical antiseptic for skin infections

Dosage

Children: Refer to the BNF for Children for paediatric dosing guidelines.

Adults: Refer to the BNF for specific dosing information based on the condition being treated.

Mechanism of action

Dichlorophen exerts its antimicrobial effects by disrupting the integrity of microbial cell membranes and inhibiting essential cellular processes. This leads to cell lysis and death in susceptible organisms. The compound's action is primarily due to its ability to denature proteins and interfere with metabolic pathways critical for microbial survival.

Pharmacodynamics

Dichlorophen demonstrates a broad spectrum of antimicrobial activity, effective against various bacteria, fungi, and some viruses. Its potency is partly attributed to its lipophilic nature, allowing it to penetrate microbial membranes easily. The drug's efficacy can vary based on the concentration used and the specific microbial strains being targeted.

Pharmacokinetics

Dichlorophen is absorbed through the gastrointestinal tract and distributed throughout the body. It undergoes hepatic metabolism, primarily through conjugation and oxidation, and is eliminated via renal pathways. The drug's half-life and clearance rates can vary depending on individual patient factors, including age, liver function, and renal status.

Contra-indications

• Hypersensitivity to dichlorophen or any of its components
• History of liver disease
• Severe renal impairment

Adverse effects

• Nausea
• Vomiting
• Abdominal pain
• Diarrhoea
• Rash
• Headache
• Dizziness
• Hepatotoxicity

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with other hepatotoxic drugs
• May alter the metabolism of other medications metabolized by the liver

Precautions

• Use with caution in patients with liver or kidney disease
• Monitor liver function during prolonged therapy
• Discontinue if signs of hepatic dysfunction occur
• Not recommended for use in children unless specifically prescribed

Pregnancy

There is limited information on the safety of dichlorophen during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if dichlorophen is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Oral suspension

Indications

• Chronic venous insufficiency
• Osteoarthritis
• Hypertension
• Diabetes
• Cardiovascular health
• Antioxidant support

Dosage

Children: Refer to a healthcare professional or product guidelines for pediatric dosing, as safety and efficacy have not been well established in children.

Adults: Refer to the specific product guidelines, as dosages can vary based on the formulation and concentration of the extract.

Mechanism of action

The active compounds in pine bark extract, particularly proanthocyanidins, exert their effects through several mechanisms. They enhance nitric oxide production, which leads to vasodilation and improved blood flow. Additionally, they inhibit the oxidation of low-density lipoprotein (LDL) cholesterol, thus contributing to cardiovascular health. The antioxidant properties help reduce oxidative stress and inflammation by scavenging free radicals and modulating inflammatory pathways.

Pharmacodynamics

Pine bark extract displays a range of pharmacodynamic effects, including vasodilatory, anti-inflammatory, and antioxidant properties. These effects can lead to improved circulation, reduced symptoms of chronic venous insufficiency, and potential benefits in conditions associated with oxidative stress. The anti-inflammatory effects may also contribute to pain relief in osteoarthritis and other inflammatory conditions.

Pharmacokinetics

The pharmacokinetics of pine bark extract are influenced by its route of administration, typically oral. After ingestion, proanthocyanidins are absorbed in the gastrointestinal tract and distributed throughout the body. They undergo metabolic conversion in the liver, with a half-life that can vary based on individual metabolism and formulation. Elimination occurs primarily through urine, with metabolites detectable for several hours post-administration.

Adverse effects

• Allergic reactions
• Skin irritation
• Headache
• Gastrointestinal disturbances

Precautions

• Use with caution in individuals with known allergies to pine products.
• Monitor for allergic reactions in sensitive individuals.

Pregnancy

Pine products should be used with caution during pregnancy. Limited data is available regarding the safety of pine in pregnancy, consult a healthcare provider before use.

Breast-feeding

Caution is advised when using pine products while breastfeeding. Consult a healthcare provider for safety information.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Essential oil
• Extracts
• Topical ointments

Indications

• Insecticide for agricultural use
• Pest control in public health

Dosage

Children: Refer to local guidelines and product-specific information.

Adults: Refer to local guidelines and product-specific information.

Mechanism of action

Propetamphos inhibits the enzyme acetylcholinesterase, which is responsible for the breakdown of the neurotransmitter acetylcholine in the synaptic cleft. The inhibition of this enzyme leads to an accumulation of acetylcholine, causing continuous stimulation of the postsynaptic receptors, ultimately resulting in neuromuscular dysfunction and paralysis in target organisms.

Pharmacodynamics

The pharmacodynamic effects of propetamphos are primarily related to its role as an acetylcholinesterase inhibitor. The increased availability of acetylcholine at synaptic sites results in prolonged stimulation of cholinergic receptors, causing muscle twitching, spasms, and eventual paralysis in pests. In humans and other mammals, high levels of exposure can lead to cholinergic toxicity, characterized by symptoms such as salivation, lacrimation, urination, diarrhea, gastrointestinal distress, muscle twitching, and respiratory failure.

Pharmacokinetics

Propetamphos is absorbed through the skin and via the gastrointestinal tract, with its distribution being influenced by its lipophilicity. It undergoes metabolic transformation primarily in the liver, where it is converted into active and inactive metabolites. The elimination half-life can vary, but it is generally excreted in urine as metabolites. Environmental degradation occurs through hydrolysis and microbial activity, affecting its persistence in the environment.

Pregnancy

There is limited data on the use of propetamphos in pregnancy. Caution is advised.

Breast-feeding

It is not known whether propetamphos is excreted in human milk. Caution is recommended.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'formulation': 'Liquid formulation', 'strength': 'specific strength not provided'}